Chr. Hansen Holding AS (CHR) - Financial and Strategic SWOT Analysis Review

Summary

Chr. Hansen Holding A/S (Chr. Hansen) is a global bioscience company, involved in the development of natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The company develops, produces and markets cultures, enzymes, probiotics and natural colors. The company caters to the needs of agriculture, beverage, ice and desserts, meat pharmaceuticals, cereal, dietary supplements, fermented milks, confectionery, cheese, fruit preparations, snacks, spreads and wine industries. The company conducts research and development in the fields of fermentation, microbial physiology, customization, screening and documentation.

Chr. Hansen Holding AS Key Recent Developments

Oct 31, 2012: Hansen Reports Revenue Of €699m In Fiscal 2012
Oct 04, 2012: Chr. Hansen's Probiotic Bacteria Strains Prevent Recurrent Urinary Tract Infections In Postmenopausal Women
Jul 04, 2012: Chr. Hansen Reports Revenue Of €181m In Q3 Fiscal 2012
Apr 19, 2012: Chr. Hansen Reports Revenue Of €165m In Q2 Fiscal 2012
Jan 11, 2012: Chr. Hansen Reports Revenue Of €168m In Q1 Fiscal 2012GDPH28292FSA

This comprehensive SWOT profile of Chr. Hansen Holding AS provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of contents

Section 1 - About the Company
Chr. Hansen Holding A/S - Key Facts
Chr. Hansen Holding A/S - Key Employees
Chr. Hansen Holding A/S - Key Employee Biographies
Chr. Hansen Holding A/S - Major Products and Services
Chr. Hansen Holding A/S - History
Chr. Hansen Holding A/S - Company Statement
Chr. Hansen Holding A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Chr. Hansen Holding A/S - Business Description
Chr. Hansen Holding A/S - Corporate Strategy
Chr. Hansen Holding A/S - SWOT Analysis
SWOT Analysis - Overview
Chr. Hansen Holding A/S - Strengths
Strength - Diversified Product Portfolio
Strength - Sturdy R&D Activities
Strength - Strong Profitability Indicators
Chr. Hansen Holding A/S - Weaknesses
Weakness - Limited Liquidity
Weakness - Legal Proceedings
Chr. Hansen Holding A/S - Opportunities
Opportunity - Key Business Initiatives
Opportunity - Product Launches
Opportunity - Growth of Pharmaceutical Market
Chr. Hansen Holding A/S - Threats
Threat - Competitive Pressures
Threat - Rise in Raw Material Prices
Threat - Rapid Technological Change/ Risk of Product Obsole
Chr. Hansen Holding A/S - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Chr. Hansen Holding A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Chr. Hansen Holding A/S, Recent Developments
Oct 31, 2012: Hansen Reports Revenue Of €699m In Fiscal 2012
Oct 04, 2012: Chr. Hansen's Probiotic Bacteria Strains Prevent Recurrent Urinary Tract Infections In Postmenopausal Women
Jul 04, 2012: Chr. Hansen Reports Revenue Of €181m In Q3 Fiscal 2012
Apr 19, 2012: Chr. Hansen Reports Revenue Of €165m In Q2 Fiscal 2012
Jan 11, 2012: Chr. Hansen Reports Revenue Of €168m In Q1 Fiscal 2012
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Chr. Hansen Holding A/S, Key Facts
Chr. Hansen Holding A/S, Key Employees
Chr. Hansen Holding A/S, Key Employee Biographies
Chr. Hansen Holding A/S, Major Products and Services
Chr. Hansen Holding A/S, History
Chr. Hansen Holding A/S, Other Locations
Chr. Hansen Holding A/S, Key Competitors
Chr. Hansen Holding A/S, Ratios based on current share price
Chr. Hansen Holding A/S, Annual Ratios
Chr. Hansen Holding A/S, Interim Ratios
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Chr. Hansen Holding A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Chr. Hansen Holding A/S, Performance Chart (2008 - 2012)
Chr. Hansen Holding A/S, Ratio Charts
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Related research categories

By company: SWOT analysis